Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000974953 | SCV001122826 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001001987 | SCV001159799 | uncertain significance | not specified | 2018-07-12 | criteria provided, single submitter | clinical testing | The SAG c.1091C>T; p.Pro364Leu variant (rs112613526) is reported in the medical literature in an individual with autosomal recessive retinitis pigmentosa, but the variant was not described as causative and the authors question the contribution of SAG variants to retinitis pigmentosa or stationary night blindness (Sippel 1998). This variant is found in the African population with an overall allele frequency of 1.9% (460/23624 alleles, including 3 homozygotes) in the Genome Aggregation Database. The amino acid at this position is highly conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Although there are indications that this variant may be benign, there is insufficient evidence to classify the variant with certainty. Therefore, considering available information, this variant is classified as uncertain. References: Sippel KC et al. Evaluation of the human arrestin gene in patients with retinitis pigmentosa and stationary night blindness. Invest Ophthalmol Vis Sci. 1998 Mar;39(3):665-70. |
Illumina Laboratory Services, |
RCV001140416 | SCV001300673 | likely benign | Retinitis pigmentosa | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001140417 | SCV001300674 | benign | Oguchi disease | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Clinical Genetics, |
RCV001001987 | SCV001925961 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000974953 | SCV001965091 | likely benign | not provided | no assertion criteria provided | clinical testing |